PDF
DataM
Optogenetics Market Report
SKU: BT1300

Optogenetics Market Size, Share, Industry, Forecast and outlook (2026-2033)

Global Optogenetics Market is segmented By Actuators (Archaerhodopsin, Channelrhodopsin, Halorhodopsin), By Light Equipment (Light Emitting Diode (LED), Laser), By Sensors (Chloride (Chameleon), Calcium (Aequorin, Cameleon, Others), Membrane Gated (Mermaid), Others), By Application (Behavioral Tracking, Neuroscience, Retinal Disease Treatment, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2026-2033

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy

Market Size & Forecast
Competitive Analysis
Partner Identification
Unmet Needs
Regulatory Compliance
Opportunity Analysis

Stop Guessing and Start Converting. 81% of our Clients purchase reports tailored to their exact business goals.

Report Summary
Table of Contents
List of Tables & Figures

Optogenetics Market Size

Report on Global Optogenetics by DataM Intelligence estimates the market to grow at a CAGR 4.1% during the forecast period 2026-2033. Demand from research labs in North America is rising. Competitive rivalry intensifies with Coherent Inc, Bruker Corporation, Regenxbio Inc and others operating in the market

Optogenetics is a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information offers an understanding of individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics is widely used in neuroscience for the modulation of neural circuits with a high degree of precision and specificity.  

Optogenetics Market Trends and Dynamics

Optogenetics Market growth is driven by technological advancements, the potential diagnostic tool in the field of neurosciences, the rapid growth of advanced technologies, and the increasing use of multimodal imaging.  The introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable untethered light delivery is also driving the market growth in the forecast period.

The rapid growth of advanced technology is driving the market growth  in the forecast period

Optogenetics technology has revolutionized neuroscience by allowing researchers to control specific neurons in experimental animals. The ability to control neurons has revealed information about brain pathways involved in diseases such as depression, obsessive-compulsive disorders, Parkinson's disease, and other conditions. In neural research, optogenetic methods for monitoring synaptic activity have proven to be extremely useful in a number of neurological diseases.

It allows researchers to study how the neurological activity patterns within specific brain cells give rise to thoughts, behaviors, and memories at an unprecedented precision level. Thus, it helps to find cures and treatments for neurological and psychiatric disorders, such as depression, addiction, schizophrenia, and Parkinson's disease. For instance, according to the article published in the Nature communication in May 2020, titled ”Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms” the precision of optogenetics holds the promise of improved normalization of circuits that are dysfunctional in Parkinson's disease as well as its diagnosis, while the use of light rather than electricity (as in deep brain stimulation) may reduce the risk of unintended effects caused by non-specific influences. Thus, the use of optogenetics in the diagnosis of Parkinson's disease has proven to be a potential tool used for diagnosis of the brain activity in Parkinson's disease. Thus, these factors are driving the growth of the market in the forecast period.

The dearth of optogenetics with integrated safety features will hamper the market growth

However, lack of awareness and the high cost of technology is the major restraining factor for the growth of the market over the forecast period. Generally, LEDs are limited to several hundred megabits/second links while lasers are good for 25-50 gigabits per second links when direct modulated. Thus, the low efficiency of optical fibers limits the use of LEDs for certain applications.

Optogenetics Market Scope and Summary

Metrics

Details

Market CAGR

4.1%

Segments Covered

By Actuators, By Light Equipment, By Sensors, By Application, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

 

For more insights - Download Sample

Optogenetics Companies and Competitive Landscape

The optogenetics market is a moderately competitive presence of local as well as global companies. Some of the key players that are contributing to the growth of the market include the Hubner group (Cobolt Inc.), Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Judges Scientific Plc (Scientifica), Shanghai Laser & Optics Century Co. Ltd, Bruker Corporation, Thorlabs Inc., Regenxbio Inc among others. 

Recent Developments

In March 2026, Bruker Corporation and Thorlabs Inc. advanced development of optogenetics systems, focusing on high-precision light delivery, miniaturized devices, and real-time neural modulation for research and clinical applications.

In February 2026, companies introduced next-generation optogenetic tools, enhancing neural control accuracy and enabling deeper tissue penetration using advanced light sources and engineered opsins.

In January 2026, growing demand for neuroscience research boosted the adoption of optogenetics across academic institutes, biotechnology firms, and pharmaceutical companies globally.

In November 2025, leading players such as GenSight Biologics, Addgene, and Danaher Corporation expanded R&D investments to accelerate the development of therapeutic and research applications.

In October 2025, increasing focus on neurological disorder treatment and precision medicine encouraged the adoption of optogenetics in applications such as Parkinson’s disease, epilepsy, and retinal disorders.

In September 2025, across regions including North America, Europe, and the Asia Pacific, rising investment in biotechnology and brain research accelerated the growth of the optogenetics market.

Laserglow Technologies

Overview:

Laserglow Technologies is an optoelectronics company headquartered in Toronto, Ontario, Canada, specializing in the sale of lasers, particularly DPSS and collimated diode lasers.   

Product Portfolio:

447 nm Collimated Diode Laser System: The LRD-0447 Series of Collimated Diode (Semiconductor) Lasers are ideal for applications requiring a short wavelength of 447 nm and output power levels of 5 mW to 20 W with a high level of long-term output power stability and long operating lifetime at a very competitive cost.

FAQ’s

  • Major players are Coherent Inc, Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Judges Scientific Plc (Scientifica), Shanghai Laser & Optics Century Co. Ltd, Bruker Corporation, Thorlabs Inc, Regenxbio Inc and Hubner group.

  • North America region Controls and dominates the Global Optogenetics Market.

  • Among all regions, Asia Pacific is the fastest-growing market share during the forecast period.

  • The optogenetics market is expected to grow at a CAGR of 4.1% during the forecasting period 2026-2033.
Related Reports